… Ayşegül Ketenci corresponding author 1 and Mert Zure 1 … Suman A, Armijo-Olivo S,
Deshpande S, Marietta-Vasquez J, Dennett L, Miciak M, et al. A systematic review of the …

Background— Time-dependent activation of matrix metalloproteinases (MMPs) after
myocardial infarction (MI) contributes to adverse left ventricular (LV) remodeling; however, …

… Singer TP, Gutman M. The DPNH dehydrogenase of the mitochondrial respiratory chain. …
Murphy E, LeFurgey A, Lieberman M. Biochemical and structural changes in cultured heart …

Background BMS-747158-02 is a fluorine 18-labeled pyridaben derivative designed as a
new myocardial perfusion imaging agent for use with positron emission tomography (PET). …

Background: Breast cancer-related lymphedema (BCRL) is a potentially debilitating complication
of breast cancer and its treatment. The aim of this study was to determine the efficacy of …

… Results: Imaging studies after 0.2 mCi/m 2 (7.4 MBq/m 2 ) show little redistribution out of
the peritoneal cavity and no significant uptake in major organs. Peak blood level of the …

Objectives : This study sought to evaluate the feasibility of noninvasive detection of matrix
metalloproteinase (MMP) activity in experimental atherosclerosis using technetium-99m–…

… Similarly, LMI1195 uptake kinetics examined in a human neuroblastoma cell line had K
m and V max values of 1.44±0.76 μmol/L and 6.05±3.09 pmol/million cells per minute, …

Background— Matrix metalloproteinase (MMP) activation plays a key role in vascular remodeling.
RP782 is a novel indium 111 In–labeled tracer with specificity for activated MMPs. We …

… Although we only tested five lysis conditions, we recommend the use of lysis buffers based
on ~0.5 M EDTA such as the Rohland buffer for aeDNA extractions from marine sediments as …